Lupin Unveils Strategic Partnership Program to Expand Reach of its Long-Acting Injectable Platform

MUMBAI, India and NAPLES, Fla., Oct. 9, 2025 /PRNewswire/ — Global pharma major Lupin Limited (Lupin) (BSE: 500257) (NSE: LUPIN) (REUTERS: LUPIN.BO) (BLOOMBERG: LPCIN) today announced the launch of a strategic partnership program aimed at expanding the reach of PrecisionSphere™ – the…